[1
]Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet,
Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden
[2
]Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Glasgow, UK
[3
]National Institute for Science and Technology on Innovation on Neglected Diseases,
Centre for Technological Development in Health, Oswaldo Cruz Foundation (Fiocruz),
Rio de Janeiro, Brazil
[4
]King’s Centre for Global Health, Global Health Offices, Weston Education Centre, Cutcombe
Road, London SE5 9RJ, UK
[5
]Sunnybrook Odette Cancer Centre, 2075 Bayview Avenue, Toronto, ON, Canada
[6
]Hauptverband der Österreichischen Sozialversicherungsträger, 21 Kundmanngasse, AT-1031,
Wien, Austria
[7
]Institute of Pharmacology and Toxicology, Department for Biomedical Sciences, University
of Vienna, Vienna, Austria
[8
]Osteba Basque Office for HTA, Ministry of Health of the Basque Country, Donostia-San
Sebastian 1, 01010, Vitoria-Gasteiz, Basque Country, Spain
[9
]NHS Tayside, Kings Cross, Dundee DD3 8EA, UK
[10
]Department of Medicine, Clinical Pharmacology Unit, Karolinska Institutet, Karolinska
University Hospital Solna, SE-17176, Stockholm, Sweden
[11
]Pharmaceutical Pricing Board, Ministry of Social Affairs and Health, PO Box 33, FI-00023
Government, Helsinki, Finland
[12
]Austrian Medicines and Medical Devices Agency, Traisengasse 5, Wien, Austria
[13
]Public Health & Intelligence Strategic Business Unit, NHS National Services Scotland,
Edinburgh EH12 9EB, UK
[14
]Centre for Primary Care, Institute of Population Health, University of Manchester,
Manchester M13 9PL, UK
[15
]NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre,
Manchester M13 9PL, UK
[16
]Unitat de Coordinació i Estratègia del Medicament, Direcció Adjunta d'Afers Assistencials,
Catalan Institute of Health, Barcelona, Spain
[17
]London School of Economics and Political Science, LSE Health, Houghton Street, London
WC2A 2AE, UK
[18
]Health Insurance Institute, Miklosiceva 24, SI-1507, Ljubljana, Slovenia
[19
]Medicines Reimbursement Department, National Health Insurance Fund, Europas a. 1,
Vilnius, Lithuania
[20
]INFARMED, Parque da Saúde de Lisboa, Avenida do Brasil 53, 1749-004, Lisbon, Portugal
[21
]Liverpool Health Economics Centre, University of Liverpool, Chatham Street, Liverpool
L69 7ZH, UK
[22
]Kassenärztliche Vereinigung Hessen, 15 Georg Voigt Strasse, DE-60325, Frankfurt am
Main, Germany
[23
]Norwegian Medicines Agency, Sven Oftedals vei 8, 0950, Oslo, Norway
[24
]Clinical Programs, Pharmacy Management, Horizon Blue Cross Blue Shield of New Jersey,
Newark, USA
[25
]Republic Institute for Health Insurance, Jovana Marinovica 2, 11000, Belgrade, Serbia
[26
]State Agency of Medicines, Nooruse 1, 50411, Tartu, Estonia
[27
]Department of Healthcare Development, Stockholm County Council, Stockholm, Sweden
[28
]HTA Consulting, Starowiślna Street, 17/3, 31-038, Cracow, Poland
[29
]Public Health School, The Medical Centre of Postgraduate Education, Kleczewska Street,
61/63, 01-813, Warsaw, Poland
[30
]NHS Greater Manchester Commissioning Support Unit, Salford, Manchester, UK
[31
]National Centre for Pharmacoeconomics, St James's Hospital, Dublin 8, Ireland
[32
]Dental and Pharmaceuticals Benefits Agency (TLV), PO Box 22520 Flemingatan 7, SE-104,
Stockholm, Sweden
[33
]University of Glasgow, Glasgow, Scotland, UK
[34
]University of Heidelberg, Institute of Pharmacology, D-69120, Heidelberg, Germany
[35
]Wissenschaftliches Institut der AOK (WIDO), Rosenthaler Straße 31, 10178, Berlin,
Germany
[36
]IRDES, 10 rue Vauvenargues, 75018, Paris, France
[37
]KU Leuven Department of Pharmaceutical and Pharmacological Sciences, 3000, Leuven,
Belgium
[38
]Faculty of Pharmacy, Comenius University and Faculty of Medicine, Slovak Medical University,
Bratislava, Slovakia
[39
]Unit for Clinical Pharmacology, University Hospital Rijeka, Krešimirova 42, 51000,
Rijeka, Croatia
[40
]Ministry of Health, Republic of Croatia, Ksaver 200a, Zagreb, Croatia
[41
]Dutch Institute for Rational Use of Medicines, 3527 GV, Utrecht, Netherlands
[42
]Institute for Optimizing Health Outcomes, 151 Bloor Street West, Suite 600, Toronto,
ON M5S 1S4, Canada
[43
]Barcelona Health Region, Catalan Health Service, Esteve Terrades 30, 08023, Barcelona,
Spain
[44
]INDOX Cancer Research Network, Cancer Epidemiology Unit, University of Oxford, Oxford,
UK
License:
This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original work is properly
cited.
